| HOME >> BIOLOGY >> TECHNOLOGY |
HARBIN, China, Nov. 4 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that it will conduct a conference call at 9:00 A.M. Eastern Time on November 10, 2008 to discuss its third quarter 2008 financial results.
Joining Mr. Yan-qing Liu, Chairman, CEO and Director of China Sky One Medical, Inc., will be Yu-bo Hao, Board Secretary. The Company plans to issue an earnings announcement prior to the call.
To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: (866) 573-1052. International callers should dial (702) 696-4500. The Conference ID for this call is 72520119.
If you are unable to participate in the call at this time, a replay will be available for fourteen days starting on Monday, November 10, 2008 at 12 P.M. Eastern Time. To access the replay, dial (800) 642-1687, international callers dial (706) 645-9291 Conference ID 72520119
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding
company. The Company engages in the manufacturing, marketing and
distribution of pharmaceutical, medicinal and diagnostic products. Through
its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and
Technology Company ("TDR") and Harbin First Bio- Engineering Company
Limited ("First"), the Company manufactures and distributes
over-the-counter pharmaceutical products, which make up its major revenue
source. For more information, visit '/>"/>
| SOURCE China Sky One Medical, Inc. Copyright©2008 PR Newswire. All rights reserved |